Capelli, Paola
 Distribuzione geografica
Continente #
EU - Europa 10.961
NA - Nord America 10.529
AS - Asia 6.913
SA - Sud America 771
AF - Africa 148
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 29.355
Nazione #
US - Stati Uniti d'America 10.349
GB - Regno Unito 3.469
RU - Federazione Russa 3.433
SG - Singapore 2.531
CN - Cina 2.487
IT - Italia 1.009
DE - Germania 622
BR - Brasile 606
SE - Svezia 606
HK - Hong Kong 507
VN - Vietnam 504
FR - Francia 460
IE - Irlanda 443
FI - Finlandia 441
KR - Corea 203
UA - Ucraina 136
TR - Turchia 123
CA - Canada 103
BD - Bangladesh 102
IN - India 101
JP - Giappone 97
NL - Olanda 68
AR - Argentina 61
BE - Belgio 53
NG - Nigeria 48
IQ - Iraq 44
PL - Polonia 44
MX - Messico 43
ES - Italia 39
ZA - Sudafrica 38
ID - Indonesia 30
VE - Venezuela 24
PK - Pakistan 23
AT - Austria 21
CH - Svizzera 20
AU - Australia 19
MA - Marocco 19
EC - Ecuador 18
IR - Iran 18
CO - Colombia 16
CL - Cile 15
SA - Arabia Saudita 15
PH - Filippine 14
CZ - Repubblica Ceca 13
PE - Perù 13
UZ - Uzbekistan 13
KZ - Kazakistan 12
LT - Lituania 11
MY - Malesia 10
JO - Giordania 9
KE - Kenya 9
PY - Paraguay 9
EG - Egitto 8
OM - Oman 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
ET - Etiopia 7
EU - Europa 7
GR - Grecia 7
LV - Lettonia 7
RO - Romania 7
IL - Israele 6
PS - Palestinian Territory 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CR - Costa Rica 5
LB - Libano 5
RS - Serbia 5
TH - Thailandia 5
TN - Tunisia 5
BO - Bolivia 4
DK - Danimarca 4
JM - Giamaica 4
KG - Kirghizistan 4
NP - Nepal 4
SV - El Salvador 4
UY - Uruguay 4
AM - Armenia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MK - Macedonia 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IM - Isola di Man 2
LU - Lussemburgo 2
Totale 29.319
Città #
Southend 3.160
Singapore 1.399
Moscow 1.172
Chandler 1.119
Ashburn 966
Jacksonville 921
San Jose 872
Dallas 819
Woodbridge 743
Ann Arbor 665
Hong Kong 501
Dublin 442
Houston 414
Beijing 377
Verona 323
The Dalles 292
New York 230
Jinan 212
Wilmington 183
Lawrence 174
Princeton 174
Los Angeles 171
Ho Chi Minh City 167
Nanjing 163
Shenyang 153
Hanoi 123
Munich 121
Helsinki 108
Hebei 103
Tianjin 89
Tokyo 82
Buffalo 79
Ningbo 76
São Paulo 72
Haikou 70
Lancaster 70
Zhengzhou 70
Changsha 68
Orem 67
Milan 65
Santa Clara 65
Nanchang 62
Columbus 59
Taizhou 59
Redondo Beach 57
Sindelfingen 55
Taiyuan 54
Brussels 51
Guangzhou 50
Hangzhou 50
Abuja 47
Boardman 47
Council Bluffs 47
Turku 42
Jiaxing 39
Warsaw 38
Chennai 37
Norwalk 37
San Francisco 36
Chicago 35
Frankfurt am Main 35
Seattle 35
Montreal 33
Rome 32
Bologna 31
London 30
Fuzhou 28
Brooklyn 27
Düsseldorf 27
Falls Church 27
Johannesburg 27
Seoul 27
Redwood City 26
Lanzhou 25
Toronto 24
Denver 23
Stockholm 23
Atlanta 21
Phoenix 21
Amsterdam 20
Dearborn 20
Poplar 20
Rio de Janeiro 20
Belo Horizonte 19
Boston 19
Mexico City 19
Washington 19
Da Nang 18
Kent 18
Ankara 17
Manchester 17
Baghdad 16
Nuremberg 16
Shanghai 16
Haiphong 15
Zurich 15
Madrid 13
Redmond 13
Biên Hòa 12
Jakarta 12
Totale 18.918
Nome #
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 374
Tumore solido cistico pseudopapillare del pancreas, descrizione di due casi pediatrici 369
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 316
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 297
Whole-genome landscape of pancreatic neuroendocrine tumours 281
Autoimmune Pancreatitis: Differences Between the Focal and Diffuse Forms in 87 Patients 276
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 256
Genomic analyses identify molecular subtypes of pancreatic cancer 251
Application of international consensus diagnostic criteria to an Italian series of autoimmune pancreatitis 248
Tumor-like lesionsof the pancreas. 242
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 240
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 237
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 234
Adenocarcinoma of the Ampulla of Vater: T-Stage, Chromosome 17p Allelic Loss, and Extended Pancreaticoduodenectomy are Relevant Prognostic Factors 231
Bisphosphonate-associated osteonecrosis can hide jaw metastases 230
Classifications of an Italian Series of Autoimmune Pancreatitis by International Consensus Diagnostic Criteria (ICDC) 230
Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions 226
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 226
Does intrahepatic cholangiocarcinoma have better prognosis compared to perhilar cholangiocarcinoma? 223
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 223
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 219
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. 217
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival. 217
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 217
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 216
CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas 214
Successful xenografting of cryopreserved primary pancreatic cancers. 213
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 213
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 211
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 210
Clinical and Morphological Features of Paraduodenal Pancreatitis: An Italian Experience With 120 Patients 208
Acinar cell cystadenoma of the pancreas: a new entity? 207
Endocrine neoplasms of the pancreas: pathologic and genetic features. 207
Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct 206
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis 205
Chromosome 3p alterations in pancreatic endocrine neoplasia 204
Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload 204
Alcohol, smoking and papillomavirus infection as risk factors for esophageal squamous-cell papilloma and esophageal squamous-cell carcinoma in Italy. 203
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 203
Beyond Pancreatic Cyst Epithelium: Evidence of Ovarian-Like Stroma in EUS-Guided Through-the-Needle Micro-Forceps Biopsy Specimens 203
Granular cell tumor of pancreas: a rare entity with a misleading presentation 202
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 199
Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: A systematic review and an exploratory meta-analysis 198
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients 197
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 197
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 197
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 196
Rare neoplasms 196
Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour 195
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation. 194
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients 193
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 192
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 192
ESGAR 2016 Book of Abstracts 192
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. 191
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 191
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 190
Presentation and Outcome of Pancreaticoduodenal Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome 188
Altered paraoxonase expression in patients with genetic haemochromatosis. 188
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 188
S100P expression in cholangiocarcinoma 187
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 187
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 187
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 186
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 185
Pancreatic Adenocarcinomas Frequently Show P53 Gene-mutations 184
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 182
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 182
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 182
Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT 181
Molteplici e sincrone neoplasie del tratto gastroenterico in un paziente affetto da neurofibromatosi di tipo 1 180
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 177
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 176
Pancreatic granulomatous necrotizing vasculitis: a case report and review of the literature. 173
Malignant pancreatic neuroendocrine tumour: Lymph node ratio and Ki67 are predictors of recurrence after curative resections 173
Establishment of a cryopreserved tissue bank and a xenografting facility for pancreatic cancer 170
Preoperative diagnosis of renal angiomyolipoma: fine needle aspiration cytology and immunocytochemical characterization 168
Rectal cancer: pathological features and their relationship to prognosis and treatment 168
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries 168
Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance 165
What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes 164
Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. 163
Preoperative assessment of intrahepatic cholangiocarcinoma: CT features with pathological correlation. 163
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 163
Autoimmune pancreatitis: pathological findings. 162
Resectable pancreatic cancer: who really benefits from resection? 162
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 162
Imaging presentation of pancreatic neuroendocrine neoplasms 162
9.14 Pancreas esocrino 161
CT texture analysis of ductal adenocarcinoma downstaged after chemotherapy 161
Pancreatic Cystic Endocrine Tumors: A Different Morphological Entity Associated with a Less Aggressive Behavior. 160
Extranodal extension is an important prognostic parameter for both colonic and rectal cancer 160
Intra-arterial and systemic chemotherapy: A new sequential approach in radically resected pancreatic cancer 159
Totally intrabiliary colorectal liver metastasis mimicking intraductal growth-type cholangiocarcinoma 159
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 157
Acoustic radiation force impulse ultrasound imaging of pancreatic cystic lesions: preliminary results 156
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. 156
Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts 155
Pathology of Endocrine Tumors 155
Serous Neoplasms 155
Totale 20.039
Categoria #
all - tutte 90.194
article - articoli 68.611
book - libri 0
conference - conferenze 14.007
curatela - curatele 385
other - altro 962
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.229
Totale 180.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 0 0 0 0 0 0 0 0 0 0 51
2021/20221.647 160 500 16 118 78 57 34 72 61 45 162 344
2022/20233.045 221 361 280 531 247 734 29 189 345 19 60 29
2023/20241.368 51 118 122 136 178 275 23 94 22 70 196 83
2024/20253.504 199 239 169 566 160 113 154 132 531 206 335 700
2025/202610.915 792 581 772 1.858 2.770 780 1.059 517 848 637 231 70
Totale 29.552